Cushing's syndrome after hemodialysis for 21 years

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 1, 2013, Pages 13-19

  Mise, Koki ^a   Ubara, Yoshifumi ^a   Sumida, Keiichi ^a   Hiramatsu, Rikako ^a   Hasegawa, Eiko ^a   Yamanouchi, Masayuki ^a   Hayami, Noriko ^a   Suwabe, Tatsuya ^a   Hoshino, Junichi ^a   Sawa, Naoki ^a   Hashimoto, Masaji ^a   Fujii, Takeshi ^a   Sasano, Hironobu ^b   Takaichi, Kenmei ^a  

^a TORANOMON HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; ALDOSTERONE; CINACALCET; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE; MEDRONATE TECHNETIUM TC 99M; PARATHYROID HORMONE; POTASSIUM; PRASTERONE SULFATE; RENIN; SPIRONOLACTONE; STEROID 17ALPHA MONOOXYGENASE; TETRACOSACTIDE;

ADRENAL CORTEX ADENOMA; ADRENAL INSUFFICIENCY; ADRENAL SCINTISCANNING; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ANURIA; ARTICLE; BODY MASS; BODY WEIGHT; BONE DENSITY; BONE SCINTISCANNING; CASE REPORT; CIRCADIAN RHYTHM; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DIET THERAPY; DRUG MEGADOSE; DRUG UPTAKE; FEMALE; HEMODIALYSIS; HIP PAIN; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOKALEMIA; KIDNEY FAILURE; LAPAROSCOPIC SURGERY; LOW DRUG DOSE; MOON FACE; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OSTEOPOROSIS; PARATHYROID DISEASE; PARATHYROID ECTOPIA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID TRANSPLANTATION; PARATHYROIDECTOMY; PHYSICAL EXAMINATION; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RELAPSE; REMISSION; SECONDARY HYPERPARATHYROIDISM; STEROID METABOLISM; STRIA;

CUSHING SYNDROME; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS;

EID: 84872064646     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2766     Document Type: Article

References (28)

1. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G 2006 Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945-1953
2. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM 2004 Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208-2218
3. Matsuda K, Shimamoto K, Ura N, Ogata H, Shizukuda Y, Iwakura M, Nozawa A, Kikuchi K, Iimura O 1989 A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatment. Endocrinol Jpn 36:681-686
4. Koshiyama H, Fujisawa T, Kuwamura N, Nakamura Y, Kanamori H, Oida E, Hara A, Suzuki T, Sasano H 2003 A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review. Endocrine 21:221-226
5. Morioka M, Yuihama S, Nakajima T, Kobayashi T, Sone A, Furukawa Y, Tanaka H, Saiki T 2002 Incidentally discovered pheochromocytoma in long-term hemodialysis patients. Int J Urol 9:700-703
6. Musso CG 2004 Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5). Int Urol Nephrol 36:469-472
7. Schena FP 2011 Management of patients with chronic kidney disease. Intern Emerg Med 6(Suppl 1):77-83
8. Bonanni A, Mannucci I, Verzola D, Sofia A, Saffioti S, Gianetta E, Garibotto G 2011 Protein-energy wasting and mortality in chronic kidney disease. Int J Environ Res Public Health 8:1631-1654
9. Weiss LM, Medeiros LJ, Vickery Jr AL 1989 Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202-206
10. Sasano H 1994 Localization of steroidogenic enzymes in adrenal cortex and its disorders. Endocr J 41:471-482
11. Sasano H, Suzuki T, Moriya T 2006 Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol 17:345-354
12. Yanase T, Sasano H, Yubisui T, Sakai Y, Takayanagi R, Nawata H 1998 Immunohistochemical study of cytochrome b5 in human adrenal gland and in adrenocortical adenomas from patients with Cushing's syndrome. Endocr J 45:89-95
13. Schlosser K, Sitter H, Rothmund M, Zielke A 2004 Assessing the site of recurrence in patients with secondary hyperparathyroidism by a simplified Casanova autograftectomy test. World J Surg 28:583-588
14. Grinspoon SK, Biller BM 1994 Clinical review 62: laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 79:923-931
15. Nugent CA, Warner HR, Dunn JT, Tyler FH 1964 Probability theory in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 24:621-627
16. Krozowski ZS, Funder JW 1983 Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80:6056-6060
17. Torpy DJ, Mullen N, Ilias I, Nieman LK 2002 Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann NY Acad Sci 970:134-144
18. Hayes Jr CP, McLeod ME, Robinson RR 1967 An extravenal mechanism for the maintenance of potassium balance in severe chronic renal failure. Trans Assoc Am Phys 80:207-216
19. Mathialahan T, Maclennan KA, Sandle LN, Verbeke C, Sandle GI 2005 Enhanced large intestinal potassium permeability in end-stage renal disease. J Pathol 206:46-51
20. Kolla V, Litwack G 2000 Transcriptional regulation of the human Na/K ATPase via the human mineralocorticoid receptor. Mol Cell Biochem 204:35-40
21. Codina J, Delmas-Mata JT, DuBose Jr TD 1998 The α-subunit of the colonic H+,K+-ATPase assembles with β1-Na+,K+-ATPase in kidney and distal colon. J Biol Chem 273:7894-7899
22. N'Gankam V, Uehlinger D, Dick B, Frey BM, Frey FJ 2002 Increased cortisol metabolites and reduced activity of 11β-hydroxysteroid dehydrogenase in patients on hemodialysis. Kidney Int 61:1859-1866
23. Steffensen C, Bak AM, Rubeck KZ, Jørgensen JO 2010 Epidemiology of Cushing's syndrome. Neuroendocrinology 92(Suppl 1):1-5
24. Wicks IP, Calligeros D, Kidson W, Bertouch JV 1987 Cushing's disease presenting with avascular necrosis of the femoral heads and complicated by pituitary apoplexy. Ann Rheum Dis 46:783-786
25. Cerletty JM, Ziebert AP, Mueller KH 1973 Avascular necrosis of the femoral head as the presenting manifestation of Cushing's disease. Clin Orthop Relat Res 97:69-73
26. Cui Q, Wang GJ, Balian G 1997 Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg Am 79:1054-1063
27. Wang GJ, Cui Q, Balian G 2000 The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res 370:295-310
28. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME 2002 Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32:94-124